Tivorsan Pharmaceuticals Achieves Key Development Milestones under its Parent Project Muscular Dystrophy and Muscular Dystrophy Association Awards | Business Wire

Tivorsan Pharmaceuticals Achieves Key Development Milestones under its Parent Project Muscular Dystrophy and Muscular Dystrophy Association Awards | Business Wire: "PROVIDENCE, R.I.--(BUSINESS WIRE)--Tivorsan Pharmaceuticals, Inc. (Tivorsan) today announced that it met its fourth (4th) set of critical milestones under its existing grants from Parent Project Muscular Dystrophy (PPMD) and Muscular Dystrophy Association (MDA). The achievement of these milestones triggers additional payments to Tivorsan pursuant to the Company’s $565,000 grant from PPMD and $1,000,000 grant from MDA."



'via Blog this'